Topical Antifungal Powder for Peristomal Fungal Rash
For a peristomal fungal rash, apply antifungal powder (such as nystatin or miconazole powder) directly to the affected skin and seal it with a skin barrier sealant before reapplying the ostomy appliance. 1
Clinical Recognition and Diagnosis
Fungal peristomal rashes present as an itchy maculopapular rash with satellite borders that develops under prolonged moisture and heat beneath the ostomy appliance. 1 This differs from irritant dermatitis (which follows the shape of leaking effluent) and allergic contact dermatitis (which takes the shape of the offending product and presents with itching and redness). 1
First-Line Treatment Protocol
- Sprinkle antifungal powder onto the affected peristomal skin 1
- Seal the powder with a skin barrier sealant to create a protective layer that allows the ostomy appliance to adhere properly 1
- Reapply the pouching system over the sealed powder 1
This approach addresses both the fungal infection and maintains appliance adherence, which is critical to prevent further moisture accumulation and worsening of the rash.
Treatment Duration and Escalation
- Continue the antifungal powder regimen with each appliance change for up to 2 weeks 1
- If no improvement occurs after 2 weeks, the patient requires further evaluation by a surgeon or enterostomal therapist to reassess the diagnosis and consider alternative etiologies such as pyoderma gangrenosum (which presents as painful ulcers with a purple halo, particularly in IBD patients) 1
Addressing Underlying Causes
The most critical step is preventing ongoing leakage that creates the moist environment allowing fungal overgrowth. 1 Evaluate and modify the pouching system to eliminate undermining and leakage, as treating the infection without addressing moisture will lead to recurrence. 2
Common Pitfalls to Avoid
- Do not apply antifungal powder without sealing it, as unsealed powder prevents proper appliance adhesion and perpetuates the leak-rash cycle 1
- Antifungal powder is ineffective for non-fungal dermatoses including irritant dermatitis, allergic contact dermatitis, and pyoderma gangrenosum 1, 3
- Fungal infections will not resolve if the pouching system continues to leak, regardless of antifungal treatment 1, 2
Alternative Considerations
While the IDSA guidelines provide extensive recommendations for systemic antifungal therapy for various candidal infections 4, topical antifungal powder remains the appropriate first-line treatment for localized peristomal fungal rashes rather than systemic agents. 1 Systemic therapy would only be warranted for extensive or refractory cases that fail topical management after proper evaluation. 4